AGL
agilon health, inc.Company with tickers: AGL
CIK
1831097
CUSIP
00857U107
Shares Outstanding
16,683,786
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,420,460,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $3,997,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $48,916,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $2.95 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $2.94 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |